1998
DOI: 10.1021/jm980522d
|View full text |Cite
|
Sign up to set email alerts
|

Phenothiazine Inhibitors of Trypanothione Reductase as Potential Antitrypanosomal and Antileishmanial Drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
59
0
5

Year Published

1999
1999
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 32 publications
(67 citation statements)
references
References 0 publications
3
59
0
5
Order By: Relevance
“…A first group of inhibitors reported were the so-called "subversive substrates", due to the futile-cycling of TR induced by redox-damaging drugs, such as nitrofurans, and naphtoquinones (Henderson et al 1988, Salmon-Chemin et al 2001. Subsequently the structure of tricyclic neuroleptic showed to be a promising backbone class of TR inhibitors, and based on computational design techniques several tricylcic compounds were investigated (Chan et al 1998, Gutierrez-Correa et al 2001. Some compounds of the series of 2-amino diphenylsulfides, that have lower neuroleptic activity than phenothiazines, were potent inhibitors of TR (Girault et al 1998).…”
Section: Trypanothione Reductasementioning
confidence: 99%
“…A first group of inhibitors reported were the so-called "subversive substrates", due to the futile-cycling of TR induced by redox-damaging drugs, such as nitrofurans, and naphtoquinones (Henderson et al 1988, Salmon-Chemin et al 2001. Subsequently the structure of tricyclic neuroleptic showed to be a promising backbone class of TR inhibitors, and based on computational design techniques several tricylcic compounds were investigated (Chan et al 1998, Gutierrez-Correa et al 2001. Some compounds of the series of 2-amino diphenylsulfides, that have lower neuroleptic activity than phenothiazines, were potent inhibitors of TR (Girault et al 1998).…”
Section: Trypanothione Reductasementioning
confidence: 99%
“…However, the exact mode of action has not been elucidated yet, it can be speculated that the cationic pyridinium moiety of the compounds may have an interaction potency with DNA and/or other biological nucleophilles 40,41 . These final compounds are capable of making ionic and hidrogen bonds as well as ion-dipol, dipol-dipol, hydrophobic interactions with biological components 40 .…”
Section: Antileishmanial Activitymentioning
confidence: 99%
“…The selection of study drugs has been eclectic and largely empiric, and their broad array defies useful classification. However, rational or structure-based drug design has also begun to be applied (40,155), with appropriate concern for validating putative therapeutic targets (19). Results for a number of the new antileishmanial compounds have been reported in just the past several years, making it difficult to judge their potential usefulness.…”
Section: New Antileishmanial Agents or Application Of Existing Drugsmentioning
confidence: 99%